Naegleria fowleri is a free‑living amoeba that thrives in ponds, lakes, slow‑moving rivers, poorly chlorinated swimming pools ...

Objective To describe and evaluate the initial indicators of the pilot implementation of miltefosine in Minas Gerais for the treatment of cutaneous leishmaniasis. Methods This is a descriptive, ...

BACKGROUND Miltefosine (MIL) is the only oral drug approved for leishmaniasis treatment, but its use is limited by gastrointestinal toxicity. Novel alkylphospholipid analogues may provide safer and ...

Steps were taken to ensure the availability of drug miltefosine through Kerala Medical Services Corporation Ltd. An online module on treatment of amoebic encephalitis will be available on state ...

The incidence of visceral leishmaniasis (VL) remains a significant health threat in endemic countries. Fixed-dose combination (FDC) of amphotericin B (AmB) and miltefosine (MLT) is a promising ...

Miltefosine Medication Information Discover comprehensive details about Miltefosine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it ...

The mice given the drugs not previously used to treat the patient (miltefosine and paromomycin) responded similarly to those infected with the sensitive strain, showing that the response to ...

An anti- cancer drug called Miltefosine has recently been approved as an experimental treatment for PAM infections. But even if patients take miltefosine, PAM has a fatality rate of more than 97%.

Miltefosine penetrates the blood-brain barrier and is relatively well tolerated by patients, Ortiz said. That's important, as many antiparasitic drugs also damage human cells, he added.

The Kerala government has received a crucial shipment of Miltefosine, a drug used to treat the deadly amoebic meningoencephalitis, donated by UAE-based entrepreneur Shamsheer Vayalil. Six recent cases ...

Miltefosine (1-O-hexadecylphosphocholine), an alkylphosphocholine and a membrane-active synthetic ether-lipid analogue, which was originally developed for cancer management.

From prompt treatment to patient’s age and health, here are a few determining factors of survival rate of the deadly brain-eating amoeba disease.